Back

Lessons from COLCOT and LoDoCo2: colchicine for secondary prevention in coronary artery disease

European Heart Journal

26 January 2021
Organised by: Logo
Read full article
ESC Journals CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes

Contributors

Nadia Bouabdallaoui
Nadia Bouabdallaoui

Author

Lucie Blondeau
Lucie Blondeau

Author

Jean-Claude Tardif
Jean-Claude Tardif

Author

Montreal Heart Institute Montreal , Canada

You may be interested in
thumbnail
Congress Presentation
Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
29 August 2020
thumbnail
ESC TV Today
Episode 10: Non-bacterial thrombotic endocarditis - Managing cardiovascular risk in transgender people
27 February 2025
thumbnail
Congress Session
Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure
17 May 2025
thumbnail
Congress Presentation
Colchicine for the secondary prevention of cardiovascular diseases: a cumulative-dose meta-analysis of randomized controlled trials including 31,397 subjects worldwide
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources